Welcome to our dedicated page for AVIENT SEC filings (Ticker: AVNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AVIENT's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AVIENT's regulatory disclosures and financial reporting.
Avient Corporation plans to sell common stock under Rule 144 through Fidelity Brokerage Services LLC on the NYSE. The filing lists how the shares were acquired, including an open market purchase on 08/24/2023 and multiple restricted stock vesting and SAR awards from 2024 to 2026 with specific share amounts.
Avient Corporation reported higher sales and earnings for the three and six months ended June 30, 2026. Second‑quarter sales were $917.0 million versus $866.5 million a year earlier, with net income attributable to common shareholders of $64.8 million and diluted EPS of $0.70, up from $52.6 million and $0.57. First‑half sales rose to $1,764.4 million from $1,693.1 million, while net income attributable to common shareholders increased to $120.5 million from $32.4 million, helped by prior‑year impairment and hosting charges that did not recur.
Gross margin expanded to 33.5% in the quarter and 32.9% year‑to‑date, supported by higher volume and cost savings. Both Color, Additives and Inks and Specialty Engineered Materials grew sales and operating income. Operating cash flow was $59.3 million for the first half, capital expenditures were $41.3 million, and the company voluntarily prepaid $50.0 million on its term loan in June, reducing total debt to $1,898.6 million and maintaining liquidity of $916.1 million.
Avient continues to carry significant environmental obligations at the Calvert City site, with an accrual of $123.1 million and disclosure that additional costs above this amount are probable and could be material as designs are refined. The company is also contesting an IRS Notice of Deficiency for the 2019 tax year totaling $23.8 million of proposed tax plus interest and a potential $4.8 million accuracy‑related penalty; no provision has been recorded.
Avient Corporation reported strong second quarter 2026 results, with sales up 5.8% to $917.0 million, driven by 4.3% organic sales growth and 1.5% favorable foreign exchange. GAAP EPS was $0.70 versus $0.57 a year ago, while adjusted EPS rose 20% to $0.96 from $0.80, exceeding prior adjusted EPS guidance of $0.89 on better-than-expected organic volume growth.
Adjusted EBITDA was $168.2 million versus $148.9 million and adjusted EBITDA margins expanded by 110 basis points to a record 18.3%, with margin expansion in both Color, Additives and Inks and Specialty Engineered Materials. Net income attributable to common shareholders increased to $64.8 million from $52.6 million.
Strong cash generation supported $50 million of debt repayment in the quarter, and the company expects to repay $100–$150 million during 2026. Long-term debt declined to $1,875.3 million from $1,922.6 million at year-end 2025. Based on year-to-date performance and demand visibility, Avient raised its 2026 adjusted EBITDA outlook to $575–$603 million and increased full-year adjusted EPS guidance to $3.10–$3.25, representing 10%–15% adjusted EPS growth over the prior year.
Avient Corporation director William A. Wulfsohn reported acquiring 1,049 shares of Avient common stock on June 30, 2026. The shares were credited at $0.00 per share as a grant under the Avient Corporation Deferred Compensation Plan for Non-Employee Directors, including dividend reinvestment. Following this compensation-related transaction, he indirectly holds 65,591.325 shares of Avient common stock through the deferred compensation plan.
Avient Corp director Patricia Verduin received a stock grant reported on Form 4. She acquired 1,049 shares of Avient common stock on a grant or award basis at no cash cost per share. After this award, she directly holds a total of 28,418 common shares, reflecting equity-based compensation rather than an open-market purchase.
Avient Corp director Kerry J. Preete reported a routine compensation-related share accrual. Preete received an acquisition of 1,049 shares of Avient common stock at a price of $0.00 per share through an indirect holding in the Avient Corporation Deferred Compensation Plan for Non-Employee Directors.
Following this grant, indirect holdings in the deferred compensation plan totaled 51,639.696 shares, while direct ownership remained at 6,688 shares. The filing notes that the indirect position includes shares acquired through a dividend reinvestment feature of the non-employee director deferred compensation plan.
AVIENT CORP director Nicolas Ernest reported an award of 1,049 shares of common stock through the company’s Deferred Compensation Plan for Non-Employee Directors. The shares, which include amounts acquired via a dividend reinvestment feature, are held indirectly, bringing his reported indirect holdings in this plan to 26,906.565 shares.
Avient Corp director Kim Ann Mink reported a routine equity compensation transaction through a deferred compensation plan. On the reported date, an account associated with the Avient Corporation Deferred Compensation Plan for Non-Employee Directors acquired 1,049 shares of common stock, including shares credited via the plan’s dividend reinvestment feature.
The shares were acquired at no cash cost per share as a grant or award and are held as an indirect interest in the plan rather than as directly owned stock. After this transaction, the filing shows 38,817.061 common shares credited to this deferred compensation plan position.
AVIENT CORP director William R. Jellison reported routine equity compensation and updated holdings. He received a grant of 1,049 shares of Common Stock as a "grant, award, or other acquisition" at a price of $0.0000 per share, bringing his direct holdings to 27,174 shares. He also has 44,123.952 indirect shares held through the Avient Corporation Deferred Compensation Plan for Non-Employee Directors, which include shares acquired via a dividend reinvestment feature.
AVIENT CORP director Neil Green reported a compensation-related stock award and updated his holdings. He received a grant or award of 1,049 shares of common stock at no stated purchase price, bringing his directly held common stock to 10,420.204 shares after the transaction. He also holds 8,743.48 shares indirectly through a deferred compensation plan that includes shares acquired via a dividend reinvestment feature for non-employee directors.